This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
Scientific Reports Open Access 01 June 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Di Gioia, M. et al. Endogenous oxidized phospholipids reprogram cellular metabolism and boost hyperinflammation. Nat. Immunol. https://doi.org/10.1038/s41590-019-0539-2 (2019)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Minton, K. DAMP-driven metabolic adaptation. Nat Rev Immunol 20, 1 (2020). https://doi.org/10.1038/s41577-019-0258-9
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41577-019-0258-9
This article is cited by
-
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
Scientific Reports (2021)
-
The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options
Current Microbiology (2021)
-
Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s)
VirusDisease (2021)
-
Within Host Dynamics of SARS-CoV-2 in Humans: Modeling Immune Responses and Antiviral Treatments
SN Computer Science (2021)